Curis, Inc. (NASDAQ:CRIS) could be among the worst stocks to invest in right now as the company shares are trading 5.51% or 0.105 points down from last closing price of $1.91, reaching $1.8048 at last check. Any clue why there is so much of action in the CRIS stock? The share price has dropped in 3 of the last 5 days and is up 76.85% over the past week. It will be exciting to see whether the stock manages to continue decreasing or take a minor break for the next few days. The move came on solid volume too with far more shares changing hands than in a normal session. Trading activity as of this writing strengthened by 53,076 shares, and in total 144976 shares valued at $261653 were seen changing hands compared with 91900 shares valued at $175529 recorded at the previous session. You should take into consideration that a greater volume on lower prices causes the situation where nobody wants to continue with their long position and wants to exit from the CRIS stock.
Curis, Inc. (CRIS) shares have notched a 3-month gain of about 76.85%, but has still advanced 176.89% year to date. By comparison, the stock sank -27.02% over the past 12 months, while it slipped -7.73% over the 1 month. The company’s market cap is around $65.44M, with its short interest ratio standing at 1.02%.
In the current trading session for CRIS, the stock witnessed two major price actions, it rose to a high of $1.8809 and was down as much as $1.7889 at one point. The high recorded is very low when compared to their 52-week high which is $0.6. The 52-week high is now at -45.27 distance from current price. Their recent low of $3.33 represents a 203.95% recovery. This data is quite important for investors who look to benefit from the recent rise of the company’s stock. The price target currently for CRIS is $9, this is above the recent high that the stock attained. Taking a look at the overall sentimental views of financial analysts, the trading pattern of this stock recently is very clear.
The stock of Curis, Inc. earned $-0.98 per share in the trailing 12 months and has a P/E ratio of -1.84. You can compare it with that of similar companies in its industry to get a sense of whether the stock you’re looking to purchase is overvalued or undervalued. Its current price to earnings ratio is lower than the ones recorded by the industry which is 69.3 and lower compared to the sector’s average of 32.55. When the P/E ratio is low let’s say below 1.0, then the stock price is considered a good value. CRIS also has P/S multiple of 5.95. This is smaller versus the 12 month P/S ratios of other companies in the same indutry. The peer average price to sales ratio is 49.5x.
The company recorded an interesting insider sale transaction by the CEO on Jan 24, 2019. A Securities and Exchanges Commission filings show that James E. Dentzer sold a total of 5,491 CRIS shares that day for a sum of around $6,205. Curis, Inc. (CRIS) insiders have acquired no shares in the stock within the past three months. In total, individual insiders traded no shares in the business, which makes up 0% of 86,064 shares that were traded over a year. In the past 12 months, insiders have purchased zero shares while the seller parted with 86,064 shares.
CRIS‘s last price was up 25.43% as compared to the average trading price of 50 days recorded at $1.44 while enlarging the period to 200 trading days, the average closing price was $1.75. At present, there are 34.26 million in the total number of common shares owned by the public and among those 27.41 million shares have been available to trade. The percentage of shares being held by the company management was 0.5% while institutions stake was 24.2%. The company has generated negative returns on equity over the last 12 months (-729.4%). It managed to keep its gross profit margin at 94.6% over the past 12 months.
When assessing the full upside of the CRIS stock, there is another set of technicals that should be looked into and considered. Its -1.25% decline from moving average of $1.83 has brought about a negative sentiment when calculated over the last 20 days. The market has allocated a beta of 2.11 to the stock. With the beta been greater than one, this implies that the company shares are theoretically more volatile than the market, something that the traders definitely are keeping an eye on.
Most of the analysts surveyed by Thomson/First Call think quite highly of Curis, Inc. — 2 analysts rate the stock as a buy with another 0 rating it strong buy. There are 0 analysts who maintain a hold rating for the stock, with 0 giving it a sell rating. Analysts arrived at a 12-month price target of $8 on shares of Curis, Inc. (NASDAQ:CRIS), which corresponds to 344.44% upside potential than its current market price of $1.8048 and implies potential despite the recent drop in the price. However, their current target price has fallen from $19 a month ago and is down handily from the consensus target of $19 a quarter ago.
In the last five years, the EPS of the company has been roughly -5.6%. Though the percentage looks disappointing, extra headwinds are emerging as looking out over a next 5-year period, with analysts estimating that their earnings will decrease annually by 0%. The revenue of the company has retreated at an average annualized rate of about -7 over the last five years. The company recently recorded a drop of -15.2%, but this figure is rather unattractive.
Let’s briefly check the hedge fund interest towards CRIS stock. Oxford Asset Management LLP added position in the company after it grew 171.1% or 22,962 shares of its common stock. The hedge fund now owns 62,250 shares worth $112,349, SEC documents show. Renaissance Technologies LLC shored up assets in the stock as 864242.3 shares have been purchased, increasing its stake by 14.3% to 987,829 shares which are currently valued at $1,782,834. In addition, Fosun International Ltd recently reported that it now owns 396,869 shares making a total of $716,269 based on the recent price. This refelects a change of 33% in their ownership.